BSX : Insider Transactions for Boston Scientific Corp

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Boston Scientific Corp (BSX)

$83.51

0.49 (0.58%) as of 4:30 Tue 9/24

Download

Exchange:

New York Stock Exchange

Security Type:

Common

Shares Out:

1,430,000,000

Market Cap:

119.42(B)

Last Volume:

5,115,203

Avg Vol:

8,194,068

52 Week Range:

$48.64 - $83.83

Level I Sector:

Health Care

Level II Sector:

Health Services

Level III Sector:

Medical Instruments & Supplies

Member Indexes:

	S&P COMPOSITE 1500		NYSE COMPOSITE
	S&P 500

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 39

Guru Rank Value : 15.1

Guru Occurances : 4


6 Months 1 Year 2 Year

Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	211,870	516,383	985,871	2,019,624
Total Sell Value	$17,081,496	$39,761,114	$66,027,416	$115,362,423
Total People Sold	4	11	11	13
Total Sell Transactions	6	20	39	78
End Date	2024-06-27	2024-03-26	2023-09-26	2022-09-26

Adjust Filter Settings

Records found: 2009

Page 46 of 81

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Moreci Stephen F

SVP, Global Sales Operations

• – –

2010-07-01

$0.00

D/D

8,000

29,177

Pedersen John B.

Pres,Uro & Womens Health

• – –

2010-07-01

$5.90

$5,658

D/D

(959)

3,502

Pedersen John B.

Pres,Uro & Womens Health

• – –

2010-07-01

$0.00

D/D

3,020

4,461

Kucheman William

EVP, Cardiology

• – –

2010-07-01

$5.90

$8,059

D/D

(1,366)

47,355

Kucheman William

EVP, Cardiology

• – –

2010-07-01

$0.00

D/D

4,300

48,721

Nicholas Peter M

Director

– • –

2010-07-01

$5.82

$145,380

I/I

(25,000)

8,181,021

Abele John E

Director

– • –

2010-07-01

$5.82

$436,535

I/I

(75,000)

1,941,949

Nicholas Peter M

Director

– • –

2010-06-30

$5.85

$146,230

I/I

(25,000)

8,206,021

Abele John E

Director

– • –

2010-06-30

$5.84

$438,160

I/I

(75,000)

2,016,949

Abele John E

Director

– • –

2010-06-29

$5.87

$440,383

I/I

(75,000)

2,091,949

Nicholas Peter M

Director

– • –

2010-06-29

$5.88

$147,088

I/I

(25,000)

8,231,021

Nicholas Peter M

Director

– • –

2010-06-28

$6.08

$152,075

I/I

(25,000)

8,256,021

Abele John E

Director

– • –

2010-06-28

$6.07

$455,345

I/I

(75,000)

2,166,949

Nicholas Peter M

Director

– • –

2010-06-25

$6.00

$150,055

I/I

(25,000)

8,281,021

Abele John E

Director

– • –

2010-06-25

$6.00

$451,210

I/I

(75,000)

2,241,949

Abele John E

Director

– • –

2010-06-24

$5.99

$449,345

I/I

(75,000)

2,316,949

Nicholas Peter M

Director

– • –

2010-06-24

$5.99

$149,710

I/I

(25,000)

8,306,021

Nicholas Peter M

Director

– • –

2010-06-23

$6.00

$149,903

I/I

(25,000)

8,331,021

Abele John E

Director

– • –

2010-06-23

$5.99

$449,258

I/I

(75,000)

2,391,949

Abele John E

Director

– • –

2010-06-22

$6.12

$459,148

I/I

(75,000)

2,466,949

Nicholas Peter M

Director

– • –

2010-06-22

$6.12

$153,058

I/I

(25,000)

8,356,021

Nicholas Peter M

Director

– • –

2010-06-21

$6.23

$155,650

I/I

(25,000)

8,381,021

Phalen Michael P.

SVP & President, Endoscopy

• – –

2010-06-21

$6.18

$5,408

D/D

(875)

26,572

Phalen Michael P.

SVP & President, Endoscopy

• – –

2010-06-21

$0.00

D/D

2,751

27,447

Abele John E

Director

– • –

2010-06-21

$6.23

$467,015

I/I

(75,000)

2,541,949

2009 Records found	Previous 40 41 42 43 44 45 46 47 48 49 Next	Page 46 of 81

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: